Results 131 to 140 of about 1,750,371 (298)
Neural and Cardiac Responses to Hypoglycemia
In the setting of insulin therapy, patients with Type 1 diabetes (T1D) are at particularly high risk for hypoglycemia (low blood sugar) because of an impaired ability of the brain to sense and respond appropriately to hypoglycemia.
Fisher, S.; Chan, O.; Reno, C.
core +1 more source
A sparse‐aware GRU model accurately predicts blood glucose levels using downsampled and limited data, achieving clinically safe forecasts even under low‐monitoring conditions. By effectively capturing glucose dynamics through residual learning, the model supports personalized diabetes self‐management, offering a practical solution for resource‐limited ...
Genet Tadese Aboye +3 more
wiley +1 more source
Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis
Introduction Impaired awareness of hypoglycemia (IAH) refers to a diminished capacity to detect hypoglycemia. IAH can result in severe and even life-threatening outcomes for individuals with diabetes, especially those in advanced stages of the disease ...
Hellena Hailu Habte-Asres +3 more
doaj +1 more source
ABSTRACT Background Fetal growth restriction (FGR) may induce redistribution of the fetal circulation to preserve perfusion of vital organs. Reduced hepatic delivery of oxygen‐ and nutrient‐rich blood may cause volumetric and morphological remodeling.
Miriam Misochnik +14 more
wiley +1 more source
Hypoglycemia and hospital mortality in critically ill patients
Prior research has indicated that adopting strict glycemic control measures might elevate the risk of hypoglycemia and result in higher mortality rates among critically ill patients.
Hsuan-Fan Yeh +3 more
doaj +1 more source
AIMS: Severe hypoglycemia can be dramatic in diabetic patients, but its long-term outcome is unknown. We aimed to describe clinical characteristics of type 2 diabetic patients hospitalized for iatrogenic hypoglycemia, and find predictors of long-term ...
TIENGO, ANTONIO +4 more
core +1 more source
Abstract Pediatric obesity and metabolic dysfunction‐associated steatotic liver disease (MASLD) prevalence has risen markedly over the past decade. Due to transition delays and workforce shortages, pediatric specialists often manage patients into young adulthood, and thus familiarity with adult pharmacotherapies for MASLD is essential.
Brandon J. Perumpail +2 more
wiley +1 more source
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a common comorbidity of pediatric obesity that predisposes patients to hepatocellular adenomas (HCAs). HCAs however are nonspecific to MASLD and warrant further evaluation. We present a case of a 16‐year‐old male with severe obesity, and persistently elevated liver enzymes ...
Carolena Trocchia +3 more
wiley +1 more source
Background Hypophosphatemia due to excessive carbohydrate administration is considered the primary pathogenesis of refeeding syndrome. However, its association with liver injury and hypoglycemia, often seen in severe malnutrition before re-nutrition ...
Hidenori Matsunaga +3 more
doaj +1 more source
Abstract Gymnema sylvestre (Retz.) R.Br. ex‐Schult., commonly known as “gurmar” or “sugar destroyer,” belongs to the Apocynaceae family and is traditionally used in Ayurveda for diabetes management. This review synthesizes ethnomedicinal evidence with contemporary pharmacological studies, to evaluate the therapeutic properties and mechanistic actions ...
Faiza Saeed +5 more
wiley +1 more source

